NeuroMetrix (Nasdaq: NURO) today announced a successful CES 2019, the world’s largest and most influential technology event, which took place January 8 – 11 in Las Vegas. Highlights of the week-long event include:
Quell® 2.0 was named a CES® 2019 Innovation Awards Honoree in the Fitness, Sports and Biotech product category, recognizing the company’s innovative application of AI + neurotechnology to manage chronic pain.
- NeuroMetrix President and CEO, Shai Gozani was a speaker at the Digital Health Summit at CES, focusing on the continued advances in healthcare.
- PC Magazine picked Quell 2.0 as one of the “Best Wearables at CES 2019”.
- The Washington Times named Quell 2.0 a “Technological Option to Opioids”.
- Digital Trends included Quell 2.0 in their list of “The best CES 2019 health gadgets”.
- Jennifer Jolly, technology expert for USA Today, and The Today Show included Quell 2.0 in her TV broadcast from the floor of CES.
For a recap of Quell at CES and a preview of coming innovation, visit Quell on YouTube.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.